ROBERTO GUARINO

ROBERTO GUARINO

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in International Journal of Environmental Health Research
Verified
Journal Article
Closed access
MTMaria Rosaria Tumolo
Maria Rosaria Tumolo
APAlessandra Panico
Alessandra Panico
Antonella De DonnoAntonella De Donno
Antonella De Donno
PMPierpaolo Mincarone
Pierpaolo Mincarone
Carlo Giacomo LeoCarlo Giacomo Leo
Carlo Giacomo Leo
SSSaverio Sabina
Saverio Sabina
Environmental contaminants exposure may lead to detrimental changes to the microRNAs (miRNAs) expression resulting in several health effects. miRNAs, small non-coding RNAs that regulate gene expression, have multiple transcript targets and thereby regulate several signalling molecules. Even a minor alteration in the abundance of one miRNA can have deep effects on global gene expression. Altered patterns of miRNAs can be responsible for changes linked to various health outcomes, suggesting that specific miRNAs are activated in pathophysiological processes. In this review, we provide an overview of studies investigating the impact of air pollution, organic chemicals, and heavy metals on miRNA expression and the potential biologic effects on humans. Abbreviations: AHRR, aryl-hydrocarbon receptor repressor; AHR, aryl-hydrocarbon receptor; As, arsenic; BCL2, B-cell lymphoma 2; BCL2L11, B-cell lymphoma 2 like 11; BCL6, B-cell lymphoma 6; BPA, bisphenol A; CVD, cardiovascular diseases; CD40, cluster of differentiation 40; CCND1, Cyclin D1; CDKN1A, cyclin-dependent kinase inhibitor 1A; Cr, chromium; CTBP1, C-terminal binding protein 1; CXCL12, C-X-C motif chemokine ligand 12; DAZAP1, deleted in azoospermia associated protein 1; DEP, diesel exhaust particles; EGFR, epidermal growth factor receptor; eNOS, endothelial nitric oxide synthase; EVs, extracellular vesicles; FAK, focal adhesion kinase; FAS, fas cell surface death receptor; FOXO, forkhead box O; HbA1c, glycated hemoglobin; Hg, mercury; HLA-A, human leukocyte antigen A; HMGB, high-mobility group protein B; IFNAR2, interferon alpha receptor subunit 2; IL-6, interleukin-6; IRAK1, interleukin 1 receptor associated kinase 1; JAK/STAT, janus kinase/signal transducers and activators of transcription; MAPK, mitogen-activated protein kinase; miRNAs, microRNAs; MVs, microvesicles; NCDs, noncommunicable diseases; NFAT, nuclear factor of activated T cells; NFkB, nuclear factor kappa B; NRF2, nuclear factor, erythroid-derived 2; NRG3, neuregulin 3; O3, ozone; OP, organophosphorus pesticides; PAHs, polycyclic aromatic hydrocarbons; Pb, lead; PCBs, polychlorinated biphenyls; PDCD4, programmed cell death 4; PDGFB, platelet derived growth factor subunit beta; PDGFR, platelet-derived growth factor receptor; PI3K/Akt, phosphoinositide-3-kinase/protein kinase B; PKA, protein kinase A; PM, particulate matter; PRKCQ, protein kinase C theta; PTEN, phosphatase and tensin homolog; SORT1, sortilin 1; TGFβ, transforming growth factor-β; TLR, toll-like receptor; TNF, tumor necrosis factors; TRAF1, tumor necrosis factors-receptor associated factors 1; TRAP, traffic-related air pollution; TREM1, triggering receptor expressed on myeloid cells 1; TRIAP1, TP53 regulated inhibitor of apoptosis 1; VCAM-1, vascular cell adhesion molecule 1; VEGFA, vascular endothelial growth factor A; XRCC2, X-ray repair cross complementing 2; YBX2, Y-box-binding protein 2; ZEB1, zinc finger E-box-binding homeobox 1; ZEB2, zinc finger E-box-binding homeobox 2; 8-OH-dG, 8-hydroxy-guanine.

16 January 2018 in International Journal for Quality in Health Care
Verified
Journal Article
Closed access
PDF file
PMPierpaolo Mincarone
Pierpaolo Mincarone
Carlo Giacomo LeoCarlo Giacomo Leo
Carlo Giacomo Leo
MTMaria del Mar Trujillo-Martín
Maria del Mar Trujillo-Martín
JMJan Manson
Jan Manson
RGROBERTO GUARINO
ROBERTO GUARINO
SSSaverio Sabina
Saverio Sabina
The importance of working toward quality improvement in healthcare implies an increasing interest in analysing, understanding and optimizing process logic and sequences of activities embedded in healthcare processes. Their graphical representation promotes faster learning, higher retention and better compliance. The study identifies standardized graphical languages and notations applied to patient care processes and investigates their usefulness in the healthcare setting. Peer-reviewed literature up to 19 May 2016. Information complemented by a questionnaire sent to the authors of selected studies. Systematic review conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Five authors extracted results of selected studies. Ten articles met the inclusion criteria. One notation and language for healthcare process modelling were identified with an application to patient care processes: Business Process Model and Notation and Unified Modeling Language™. One of the authors of every selected study completed the questionnaire. Users’ comprehensibility and facilitation of inter-professional analysis of processes have been recognized, in the filled in questionnaires, as major strengths for process modelling in healthcare. Both the notation and the language could increase the clarity of presentation thanks to their visual properties, the capacity of easily managing macro and micro scenarios, the possibility of clearly and precisely representing the process logic. Both could increase guidelines/pathways applicability by representing complex scenarios through charts and algorithms hence contributing to reduce unjustified practice variations which negatively impact on quality of care and patient safety.

10 December 2019 in Journal of Ambient Intelligence and Humanized Computing
Verified
Journal Article
Closed access
PDF file
Antonio Vincenzo RadognaAntonio Vincenzo Radogna
Antonio Vincenzo Radogna
NFNicola Fiore
Nicola Fiore
MTMaria Rosaria Tumolo
Maria Rosaria Tumolo
VLValerio De Luca
Valerio De Luca
LPLucio T. De Paolis
Lucio T. De Paolis
SSSaverio Sabina
Saverio Sabina

27 December 2012 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
EGEmilio Antonio Luca Gianicolo
Emilio Antonio Luca Gianicolo
ABAntonella Bruni
Antonella Bruni
EREnrico Rosati
Enrico Rosati
SSSaverio Sabina
Saverio Sabina
RGROBERTO GUARINO
ROBERTO GUARINO
GLGiuseppe Latini
Giuseppe Latini
Congenital anomalies and their primary prevention are a crucial public health issue. This work aimed to estimate the prevalence of congenital anomalies in Brindisi, a city in southeastern Italy at high risk of environmental crisis.

25 October 2021 in Epigenomics
Verified
Journal Article
Closed access
Carlo Giacomo LeoCarlo Giacomo Leo
Carlo Giacomo Leo
PMPierpaolo Mincarone
Pierpaolo Mincarone
MTMaria Rosaria Tumolo
Maria Rosaria Tumolo
APAlessandra Panico
Alessandra Panico
Marcello GuidoMarcello Guido
Marcello Guido
SSSaverio Sabina
Saverio Sabina
Aim: A systematic review was conducted to identify the association of miRNA expression with HIV pathogenesis, progression and treatment. Methods: A search of articles was conducted in MEDLINE®, Coc... Lay abstract miRNAs play important role in the regulation of gene expression and are involved in various physiological processes. Dysregulation of their function can lead to human diseases includin...

Verified
Journal Article
Open access
PDF file
Luana ConteLuana Conte
Luana Conte
MTMaria Rosaria Tumolo
Maria Rosaria Tumolo
Giorgio De NunzioGiorgio De Nunzio
Giorgio De Nunzio
UGUgo De Giorgi
Ugo De Giorgi
RGROBERTO GUARINO
ROBERTO GUARINO
FCFederico Cucci
Federico Cucci
Breast cancer (BC) is one of the most common malignancies among women worldwide. Despite advances in early detection and treatment, prognosis remains highly variable. Molecular biomarkers, such as microRNAs (miRNAs), have emerged as promising tools to refine prognostic assessment. Among them, miR-21 is consistently overexpressed in solid tumors and implicated in key oncogenic pathways. This systematic review and meta-analysis aimed to clarify the prognostic significance of miR-21 in BC and explore its molecular mechanisms through bioinformatic analyses. A systematic search of PubMed, Scopus, and Web of Science up to April 2025 identified 18 eligible observational studies. Pooled analyses showed that high miR-21 expression was significantly associated with poorer overall survival (OS) (HR = 2.37, 95% CI: 1.42–3.98) and recurrence-related outcomes (DFS/RFS) (HR = 2.10, 95% CI: 1.32–3.34). Subgroup analyses confirmed robust associations across different cut-off definitions and revealed particularly strong effects in triple-negative BC (HR = 5.69) and mixed subtypes (HR = 2.55), but no significant association in HER2-positive BC. Bioinformatic analysis identified target genes such as PTEN, BCL2, STAT3, and MYC, involved in apoptosis regulation, proliferation, NF-κB signaling, and immune modulation. These findings provide consistent evidence that miR-21 is a promising minimally invasive prognostic biomarker in BC, particularly in aggressive subtypes, and support its integration into future multimodal prognostic models.